Nexgel (NXGLW) EBITDA Margin (2018 - 2025)

Nexgel (NXGLW) reported EBITDA Margin of 54.72% for Q4 2025, up 8238.0% on a YoY basis from 0.66% in Q4 2024, and up 321.45% quarter-over-quarter from 24.71% in Q3 2025.

Nexgel (NXGLW) EBITDA Margin (2018 - 2025) Analysis & Trends

Nexgel has reported EBITDA Margin for 8 years, with the latest figure at 54.72% in Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin rose 8238.0% year-over-year to 54.72%; the trailing twelve-month figure through Dec 2025 stood at 5.32% (up 3559.0% YoY), and the FY2025 full-year result was 5.32%, up 3558.0% from the prior year.
  • EBITDA Margin for Q4 2025 stood at 54.72%, up from 24.71% in the prior quarter.
  • The five-year high for EBITDA Margin was 54.72% in Q4 2025, with the low at 205.05% in Q1 2022.
  • Historically, EBITDA Margin has averaged 96.36% across 5 years, with a median of 92.93% in 2024.
  • Annual changes were most pronounced in 2021 — EBITDA Margin surged 50289 bps — and 2022, when it tumbled 1029 bps.
  • Nexgel's EBITDA Margin stood at 166.42% in 2021, then gained by 10 bps to 149.05% in 2022, then grew by 24 bps to 112.66% in 2023, then jumped by 75 bps to 27.66% in 2024, then surged by 298 bps to 54.72% in 2025.
  • The last three EBITDA Margin figures came in at 54.72% (Q4 2025), 24.71% (Q3 2025), and 22.05% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 28.86%
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 1.97%
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 1.63%
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 34.92%
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 20.96%
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 4.04%
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -9.90%
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 13.65%
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 2.44%
10 Nexgel - - 819,000.00 54.72%

Historic Data

Download Data
DateValue
Dec 31, 2025 54.72%
Sep 30, 2025 -24.71%
Jun 30, 2025 -22.05%
Mar 31, 2025 -27.69%
Dec 31, 2024 -27.66%
Sep 30, 2024 -26.80%
Jun 30, 2024 -73.19%
Mar 31, 2024 -68.80%
Dec 31, 2023 -112.66%
Sep 30, 2023 -50.12%
Jun 30, 2023 -65.30%
Mar 31, 2023 -142.42%
Dec 31, 2022 -149.05%
Sep 30, 2022 -182.57%
Jun 30, 2022 -127.99%
Mar 31, 2022 -205.05%
Dec 31, 2021 -166.42%
Sep 30, 2021 -182.09%
Jun 30, 2021 -132.61%
Mar 31, 2021 -194.76%